| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |